Expenditures for the care of HIV-infected patients in the era of highly active antiretroviral therapy.

Bozzette, S A; Joyce, G; McCaffrey, D F; Leibowitz, A A; Morton, S C; Berry, S H; Rastegar, A; Timberlake, D; Shapiro, M F; Goldman, D P

Bozzette, S A; Joyce, G; McCaffrey, D F; Leibowitz, A A; Morton, S C; Berry, S H; Rastegar, A; Timberlake, D; Shapiro, M F; Goldman, D P.

Affiliation

Bozzette SA; RAND Health, Santa Monica, California 90407-2318, USA. sbozzette@ucsd.edu

N Engl J Med ; 344(11): 817-23, 2001 Mar 15.

Article in En | MEDLINE | ID: mdl-11248159

Subject(s)

Antiretroviral Therapy, Highly Active/economics; HIV Infections/economics; Health Expenditures/trends; Adult; Drug Costs/statistics & numerical data; Drug Costs/trends; Female; HIV Infections/drug therapy; Health Expenditures/statistics & numerical data; Hospital Costs/statistics & numerical data; Hospital Costs/trends; Humans; Insurance, Health; Male; Random Allocation; Socioeconomic Factors; United States

Search on Google

XML

PubMed Links

Collection: 01-internacional Health context: 1_ASSA2030 / 2_ODS3 / 4_TD Database: MEDLINE Main subject: HIV Infections / Health Expenditures / Antiretroviral Therapy, Highly Active Type of study: Clinical_trials / Health_economic_evaluation Limits: Adult / Female / Humans / Male Country/Region as subject: America do norte Language: En Journal: N Engl J Med Year: 2001 Document type: Article

Search on Google

XML

PubMed Links